A novel anti-diabetic drug, miglitol, markedly reduces myocardial infarct size in rabbits (Q35041802)

6 August 2017

A novel anti-diabetic drug, miglitol, markedly reduces myocardial infarct size in rabbits (English)

1 reference

6 August 2017

S Minatoguchi

1

1 reference

6 August 2017

M Arai

2

1 reference

6 August 2017

Y Uno

3

1 reference

6 August 2017

T Kariya

4

1 reference

6 August 2017

Y Nishida

5

1 reference

6 August 2017

K Hashimoto

6

1 reference

6 August 2017

M Kawasaki

7

1 reference

6 August 2017

G Takemura

8

1 reference

6 August 2017

T Fujiwara

9

1 reference

6 August 2017

H Fujiwara

10

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

British Journal of Pharmacology

6 August 2017

1 reference

6 August 2017

128

1 reference

6 August 2017

1667-1672

1 reference

6 August 2017

8

1 reference

Loss of myocardial protection after preconditioning correlates with the time course of glycogen recovery within the preconditioned segment.

6 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1571807

Preconditioning protects ischemic rabbit heart by protein kinase C activation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1571807

8 July 2018

New hypoglycaemic agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1571807

Pharmacology of alpha-glucosidase inhibition.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1571807

Comparison of miglitol and glibenclamide in diet-treated type 2 diabetic patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1571807

Nucleoside transport inhibitors enhance the infarct size-limiting effect of ischemic preconditioning.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1571807

Early phase acute myocardial infarct size quantification: Validation of the triphenyl tetrazolium chloride tissue enzyme staining technique

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1571807

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1571807

Acceleration of cell necrosis following reperfusion after ischemia in the pig heart without collateral circulation.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1571807

Determination of buffering capacity of rat myocardium during ischemia.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1571807

Effects of 8-wk alpha-glucosidase inhibition on metabolic control, C-peptide secretion, hepatic glucose output, and peripheral insulin sensitivity in poorly controlled type II diabetic patients.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1571807

The antiglycogenolytic action of 1-deoxynojirimycin results from a specific inhibition of the alpha-1,6-glucosidase activity of the debranching enzyme

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1571807

Ischemic preconditioning reduces infarct size in swine myocardium

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1571807

Inhibition of protein synthesis does not block myocardial protection afforded by preconditioning.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1571807

Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1571807

Energy metabolism in preconditioned and control myocardium: Effect of total ischemia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1571807

The transient nature of the effect of ischemic preconditioning on myocardial infarct size and ventricular arrhythmia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1571807

Dipyridamole potentiates the myocardial infarct size-limiting effect of ischemic preconditioning

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1571807

Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1571807

N-methyl-1-deoxynojirimycin (MOR-14), an alpha-glucosidase inhibitor, markedly reduced infarct size in rabbit hearts.

8 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702970

Infarct size-reducing effect of ischemic preconditioning is related to alpha1b-adrenoceptors but not to alpha1a-adrenoceptors in rabbits.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1571807

Preconditioning ischemia time determines the degree of glycogen depletion and infarct size reduction in rat hearts

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1571807

Superoxide dismutase and N-2-mercaptopropionyl glycine attenuate infarct size limitation effect of ischaemic preconditioning in the rabbit.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1571807

Acute hyperglycemia abolishes ischemic preconditioning in vivo

25 October 2018

1 reference

12 December 2020

Role of glycolytic products in damage to ischemic myocardium. Dissociation of adenosine triphosphate levels and recovery of function of reperfused ischemic hearts

1 reference

12 December 2020

1-Deoxynojirimycin and related compounds inhibit glycogenolysis in the liver without affecting the concentration of phosphorylase a

1 reference

12 December 2020

Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode

1 reference

12 December 2020

Ischemic preconditioning preserves creatine phosphate and intracellular pH

1 reference

12 December 2020

Anti-ischaemic actions of potassium channel openers in experimental myocardial ischaemia/reperfusion injury in dogs

1 reference

12 December 2020

Effect of angina pectoris on myocardial protection in patients with reperfused anterior wall myocardial infarction: retrospective clinical evidence of "preconditioning"

1 reference

12 December 2020

Role of bradykinin in protection of ischemic preconditioning in rabbit hearts

1 reference

12 December 2020

Glycogen depletion contributes to ischemic preconditioning in the rat heart in vivo

1 reference

12 December 2020

Early ischemia after complete coronary ligation in the rabbit, dog, pig, and monkey

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJP.0702970

1 reference

6 August 2017

1 reference

6 August 2017

1 reference